Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia

References

• Amromin GD, Boder E, Teplitz R. 1979. Ataxia-telangiectasia with a 32 year survival. A clinicopathological report. J Neuropathol Exp Neurol 38:621–643
   PubMed Web of Science ®Google Scholar
• Arasimowicz E, Pietrucha B, Rózdzyńska A, Herpolitańska-Pliszka E. 2009. Differences in the head and body structure among children with the ataxia-telangiectasia syndrome. Pediatr Endocrinol Diabetes Metab 15:196–202
   Google Scholar
• Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, et al. 1996. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86:159–171
   PubMed Web of Science ®Google Scholar
• Birkebaek NH, Wolthers OD, Heuch C, Balslev T, Flyvbjerg A, Frystyk J. 2011. Growth hormone treatment, final height, insulin-like growth factors, ghrelin, and adiponectin in four siblings with Seckel syndrome. J Pediatr Endocrinol Metab 24:995–1000
   Google Scholar
• Boder E. 1985. Ataxia-telangiectasia: An overview. Kroc Found Ser 19:1–63
   PubMedGoogle Scholar
• Boder E, Sedgwick RP. 1958. Ataxia-telangiectasia: A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526–554
   PubMed Web of Science ®Google Scholar
• Casper AM, Durkin SG, Arlt MF, Glover TW. 2004. Chromosomal instability at common fragile sites in Seckel syndrome. Am J Hum Genet 75:654–660
   Google Scholar
• Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. 2012. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 7:13 . doi: 10.1186/1750-1172-7-13
   PubMed Web of Science ®Google Scholar
• Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, et al. 1988. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336:577–580
   PubMed Web of Science ®Google Scholar
• Gotoff SP, Amirmokri E, Liebner EJ. 1967. Ataxia telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child 114:617–625
   PubMedGoogle Scholar
• Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12:9–22
   PubMed Web of Science ®Google Scholar
• Hoche F, Seidel K, Theis M, Vlaho S, Schubert R, Zielen S, Kieslich M. 2012. Neurodegeneration in ataxia telangiectasia: What is new? What is evident? Neuropediatrics 43:119–129
   PubMed Web of Science ®Google Scholar
• Hong R, Ammann AJ. 1970. Ataxia telangiectasia. N Engl J Med 283:660
   Google Scholar
• Isgaard J, Aberg D, Nilsson M. 2007. Protective and regenerative effects of the GH/IGF-I axis on the brain. Minerva Endocrinol 32:103–113
   PubMedGoogle Scholar
• Kieslich M, Hoche F, Reichenbach J, Weidauer S, Porto L, Vlaho S, Schubert R, Zielen S. 2010. Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age. Cerebellum 9:190–197
   PubMed Web of Science ®Google Scholar
• Kovacs K, Giannini C, Scheithauer BW, Stefaneanu L, Lloyd RV, Horvath E. 1997. Pituitary changes in ataxia-telangiectasia syndrome: An immunocytochemical, in situ hybridization, and DNA cytometric study of three cases. Endocr Pathol 8:195–203
   Google Scholar
• Lavin MF. 2008. Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759–769
   PubMed Web of Science ®Google Scholar
• Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM. 2000. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 136:225–231
   PubMed Web of Science ®Google Scholar
• Lefton-Greif MA, Crawford TO, McGrath-Morrow S, Carson KA, Lederman HM. 2011. Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia. Orphanet J Rare Dis 6:23. doi: 10.1186/1750-1172-6-23
   Google Scholar
• Martínez AS, Domené HM, Ropelato MG, Jasper HG, Pennisi PA, Escobar ME, Heinrich JJ. 2000. Estrogen priming effect on growth hormone (GH) provocative test: A useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab 85:4168–4172
   Google Scholar
• McGrath-Morrow SA, Gower WA, Rothblum-Oviatt C, Brody AS, Langston C, Fan LL, Lefton-Greif MA, et al. 2010. Evaluation and management of pulmonary disease in ataxia-telangiectasia. Pediatr Pulmonol 45:847–859
   PubMed Web of Science ®Google Scholar
• Morgan JL, Holcomb TM, Morrissey RW. 1968. Radiation reaction in ataxia telangiectasia. Am J Dis Child 116:557–558
   PubMedGoogle Scholar
• Morita Y, Maravei DV, Bergeron L, Wang S, Perez GI, Tsutsumi O, Taketani Y, et al. 2001. Caspase-2 deficiency prevents programmed germ cell death resulting from cytokine insufficiency but not meiotic defects caused by the loss of ataxia telangiectasia-mutated (ATM) gene function. Cell Death Differ 8:614–620
   PubMed Web of Science ®Google Scholar
• Nance MA, Berry SA. 1992. Cockayne syndrome: Review of 140 cases. Am J Med Genet 42:68–84
   PubMed Web of Science ®Google Scholar
• Pozzo AM, Kemp SF. 2012. Growth and growth hormone treatment in children with chronic diseases. Endocrinol Metab Clin North Am 41:747–759
   Google Scholar
• Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. 2004. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet 363:1346–1353
   PubMed Web of Science ®Google Scholar
• Saviozzi S, Saluto A, Taylor AM, Last JI, Trebini F, Paradiso MC, Grosso E, et al. 2002. A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA. J Med Genet 39:57–61
   PubMedGoogle Scholar
• Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. 1995. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025–2032
   PubMed Web of Science ®Google Scholar
• Schroeder SA, Swift M, Sandoval C, Langston C. 2005. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 39:537–543
   PubMed Web of Science ®Google Scholar
• Schroeder SA, Zielen S. 2013. Infections of the respiratory system in patients with ataxia-telangiectasia. Pediatr Pulmonol 49:389–399
   Google Scholar
• Schubert R, Reichenbach J, Zielen S. 2005. Growth factor deficiency in patients with ataxia telangiectasia. Clin Exp Immunol 140:517–519
   PubMed Web of Science ®Google Scholar
• Schubert R, Schmitz N, Pietzner J, Tandi C, Theisen A, Dresel R, Christmann M, Zielen S. 2009. Growth hormone supplementation increased latency to tumourigenesis in Atm-deficient mice. Growth Factors 27:265–273
   PubMed Web of Science ®Google Scholar
• Shahrabani-Gargir L, Pandita TK, Werner H. 2004. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. Endocrinology 145:5679–5687
   PubMedGoogle Scholar
• Silvestri G, Masciullo M, Piane M, Savio C, Modoni A, Santoro M, Chessa L. 2010. Homozygosity for c 6325TG transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia. J Neurol 257:1738–1740
   PubMed Web of Science ®Google Scholar
• Stahnke N. 1992. Leukemia in growth-hormone-treated patients: An update, 1992. Horm Res 38:56–62
   PubMedGoogle Scholar
• Strich SJ. 1966. Pathological findings in three cases of ataxia-telangiectasia. J Neurol Neurosurg Psychiatr 29:489–499
   Web of Science ®Google Scholar
• Tavani F, Zimmerman RA, Berry GT, Sullivan K, Gatti R, Bingham P. 2003. Ataxia-telangiectasia: The pattern of cerebellar atrophy on MRI. Neuroradiology 45:315–319
   Google Scholar
• Taylor AM, Metcalfe JA, Thick J, Mak YF. 1996. Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423–438
   PubMed Web of Science ®Google Scholar
• Tolbert DL, Clark BR. 2003. GDNF and IGF-I trophic factors delay hereditary Purkinje cell degeneration and the progression of gait ataxia. Exp Neurol 183:205–219
   PubMed Web of Science ®Google Scholar
• Vardatsikos G, Sahu A, Srivastava AK. 2009. The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications. Antioxid Redox Signal 11:1165–1190
   PubMed Web of Science ®Google Scholar
• Verhagen MMM, Last JI, Hogervorst FBL, Smeets DFCM, Roeleveld N, Verheijen F, Catsman-Berrevoets CE, et al. 2012. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotype-phenotype study. Hum Mutat 33:561–571
   PubMed Web of Science ®Google Scholar
• Wajnrajch MP, Gertner JM, Huma Z, Popovic J, Lin K, Verlander PC, Batish SD, et al. 2001. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 107:744–754
   PubMed Web of Science ®Google Scholar
• Woods CG, Taylor AM. 1992. Ataxia telangiectasia in the British Isles: The clinical and laboratory features of 70 affected individuals. Q J Med 82:169–179
   PubMedGoogle Scholar
• Wullschleger S, Loewith R, Hall MN. 2006. TOR signaling in growth and metabolism. Cell 124:471–484
   PubMed Web of Science ®Google Scholar
• Yang DQ, Kastan MB. 2000. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2:893–898
   PubMed Web of Science ®Google Scholar
• Yanofsky RA, Seshia SS, Dawson AJ, Stobart K, Greenberg CR, Booth FA, Prasad C, et al. 2009. Ataxia-telangiectasia: Atypical presentation and toxicity of cancer treatment. Can J Neurol Sci 36:462–467
   PubMed Web of Science ®Google Scholar
• Zielen S, Schubert R. 2011. Workshop report: European workshop on ataxia-telangiectasia, Frankfurt, 2011. J Neurogenet 25:78–81
   PubMed Web of Science ®Google Scholar